Detalhe da pesquisa
1.
Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
J Urol
; 211(1): 63-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796473
2.
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
J Urol
; 211(3): 415-425, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147400
3.
Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration.
Int J Mol Sci
; 25(9)2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732167
4.
Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysis.
Prostate
; 83(3): 259-267, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344473
5.
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results.
Oncologist
; 28(5): e309-e312, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994854
6.
Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate Cancer.
J Urol
; 209(3): 485-493, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472138
7.
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study.
J Urol
; 209(5): 890-900, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026631
8.
Benign prostate hyperplasia as a potential protective factor against prostate cancer: Insights from a magnetic resonance imaging study of compositional characteristics.
Prostate
; 81(14): 1097-1104, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375453
9.
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.
J Urol
; 205(2): 554-560, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090917
10.
Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.
BJU Int
; 127(5): 544-552, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037765
11.
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
Prostate
; 80(6): 527-544, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130741
12.
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data.
J Urol
; 203(4): 743-750, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580749
13.
Editorial Comment.
J Urol
; 211(6): 773-774, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721937
14.
Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
J Urol
; 211(3): 482, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179977
16.
Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation.
J Urol
; 194(2): 578-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25839382
17.
Chromogranin A staining as a prognostic variable in newly diagnosed Gleason score 7-10 prostate cancer treated with definitive radiotherapy.
Prostate
; 74(5): 520-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375481
18.
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study.
Int Urol Nephrol
; 56(1): 87-96, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725274
19.
Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules.
Int Urol Nephrol
; 56(2): 467-473, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777637
20.
Comparison of Polymerase Chain Reaction and Urine Culture in the Evaluation of Patients with Complex Urinary Tract Infections.
Biology (Basel)
; 13(4)2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666869